Pregnyl (hCG) Dosing for Testosterone Withdrawal Treatment
For treating testosterone withdrawal symptoms, the recommended dose of Pregnyl (human chorionic gonadotropin, hCG) is 500-1,000 USP Units administered three times weekly for hypogonadotropic hypogonadism in males. 1
Dosing Regimens for Hypogonadotropic Hypogonadism
The FDA-approved dosing regimens for hypogonadotropic hypogonadism in males include:
- 500 to 1,000 USP Units three times a week for three weeks, followed by the same dose twice a week for three weeks 1
- 4,000 USP Units three times weekly for six to nine months, followed by dose reduction to 2,000 USP Units three times weekly for an additional three months 1
Administration Method
Pregnyl can be administered through two routes:
- Intramuscular injection (traditional method): The FDA label specifies "intramuscular use only" 1
- Subcutaneous injection: Research shows bioequivalent absorption compared to intramuscular administration 2
While the FDA label specifies intramuscular administration, studies have demonstrated that subcutaneous administration produces comparable testosterone levels and may be preferred by patients due to ease of self-administration 3.
Reconstitution Guidelines
For proper reconstitution of Pregnyl:
- For multiple dose administration: Dilute with 10 mL bacteriostatic water for injection to achieve 1,000 IU/mL (10,000 IU vial) or 500 IU/mL (5,000 IU vial) 1
- Refrigerate between doses 1
- Inspect visually for particulate matter before administration 1
Monitoring During Treatment
When initiating hCG therapy, monitor:
- Testosterone levels: Check midway between injections (day 7-10 for biweekly injections) 4
- Hematocrit/hemoglobin: Monitor regularly as testosterone therapy can increase risk of erythrocytosis 4
- Cardiovascular risk factors: Assess before and during treatment 5
Clinical Benefits and Considerations
hCG therapy for testosterone withdrawal has shown several benefits:
- Improvement in erectile dysfunction (86%) and libido (80%) 6
- Preservation of spermatogenesis, which is important for men interested in fertility 7
- Establishment of physiological diurnal testosterone rhythm in some patients 3
Potential Side Effects and Precautions
Be aware of potential adverse effects:
- Erythrocytosis: Injectable testosterone formulations carry greater risk of increased hematocrit 4
- Gynecomastia: While uncommon, monitor for breast symptoms 5
- Fertility impact: Discuss implications for future fertility with patients 5
Contraindications
hCG therapy is contraindicated in:
Follow-up Schedule
- Initial follow-up: 1-2 months after initiating therapy
- Subsequent monitoring: Every 3-6 months during the first year
- Long-term: Yearly once stable 4
hCG therapy can effectively manage testosterone withdrawal symptoms while potentially preserving fertility, making it a valuable option for men experiencing symptoms after discontinuing testosterone therapy.